|
|
 |
|
Viewing report
|
|
|
|
Medical Affairs: Delivering Strategic Value
Cutting Edge Information, March 2008, Pages: 119
- Allergan
- Amgen
- Amylin
- Bayer
- Biogen Idec
- CV Therapeutics
- Dentsply Rinn
- Dyax
- EMD Serono
- GlaxoSmithKline
- Janssen Ortho-McNeil
- Novartis
- Sirion Therapeutics
- Upsher-Smith
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Medical Affairs Resources, Structures and Trends
Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success
Pharmaceutical Regulatory Affairs in the EU & US
Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices
Pharmaceutical Medical Publications: Market Preparation & Strategic Support
Veterans Affairs: Agency Account Planner
The Changing MSL Role: Proving Value through Performance Measurement
Australian Public Sector: Department of Families, Housing, Community Services and Indigenous Affairs
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in the Fourth Quarter of 2004
The Toolkit for Diabetes MSL Programs (PH130)
Medical Imaging Markets
|
|
|
|
